The epidermal growth factor receptor (EGFR), an important transmembrane tyrosine kinase receptor, is often overexpressed or mutated in non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer [1]. The gene discussed is EGFR; the disease is lung carcinoma.